相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
Brita Singers Sorensen et al.
FRONTIERS IN ONCOLOGY (2020)
A rational mouse model to detect on-target, off-tumor CAR T cell toxicity
Mauro Castellarin et al.
JCI INSIGHT (2020)
PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo
Qibin Liao et al.
BIOMARKER RESEARCH (2020)
Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing
Qibin Liao et al.
BIOMARKER RESEARCH (2020)
Hypoxia-targeted drug delivery
Amit Sharma et al.
CHEMICAL SOCIETY REVIEWS (2019)
Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs
Christina M. Rollings et al.
SCIENCE SIGNALING (2018)
Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs
Christina M. Rollings et al.
SCIENCE SIGNALING (2018)
Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy
Ishna N. Mistry et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery via Glial Scar Degradation and Angiogenesis in Delayed Stroke
Hongxia Cai et al.
MOLECULAR THERAPY (2017)
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
Purnima Bhat et al.
CELL DEATH & DISEASE (2017)
An oxygen sensitive self-decision making engineered CAR T-cell
Alexandre Juillerat et al.
SCIENTIFIC REPORTS (2017)
C2H2 Zinc Finger Proteins: The Largest but Poorly Explored Family of Higher Eukaryotic Transcription Factors
A. A. Fedotova et al.
ACTA NATURAE (2017)
Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy
Bita Javan et al.
ECANCERMEDICALSCIENCE (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
Zinc-finger proteins in health and disease
Matteo Cassandri et al.
CELL DEATH DISCOVERY (2017)
Hypoxic tumor microenvironment: Opportunities to develop targeted therapies
Akhil Patel et al.
BIOTECHNOLOGY ADVANCES (2016)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
Kole T. Roybal et al.
CELL (2016)
Hypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and Transactivity
Thomas Kietzmann et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor
Joost H. van den Berg et al.
MOLECULAR THERAPY (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A Hypoxia-Responsive Glial Cell-Specific Gene Therapy Vector for Targeting Retinal Neovascularization
Manas R. Biswal et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
Guillaume Collet et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Hyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy
Mario Di Matteo et al.
MOLECULAR THERAPY (2014)
Hypoxia as a target for tissue specific gene therapy
Taiyoun Rhim et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Hypoxia-Response Element (HRE)-Directed Transcriptional Regulation of the Rat Lysyl Oxidase Gene in Response to Cobalt and Cadmium
Song Gao et al.
TOXICOLOGICAL SCIENCES (2013)
Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy
T. Cherry et al.
GENE THERAPY (2010)
piggyBac Transposon-mediated Long-term Gene Expression in Mice
Hideyuki Nakanishi et al.
MOLECULAR THERAPY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment
Hongsung Kim et al.
MOLECULAR THERAPY (2008)
Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4
Dawn E. Post et al.
CANCER RESEARCH (2007)
Optimized production and concentration of lentiviral vectors containing large inserts
Nadya Al Yacoub et al.
JOURNAL OF GENE MEDICINE (2007)
Cell-specific regulation of hypoxia-inducible factor (HIF)-1α and HIF-2α stabilization and transactivation in a graded oxygen environment
Cameron P. Bracken et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Zinc finger tools: custom DNA-binding domains for transcription factors and nucleases
Jeffrey G. Mandell et al.
NUCLEIC ACIDS RESEARCH (2006)
Hypoxia-regulated expression of attenuated diphtheria toxin a fused with hypoxia-inducible factor-1α oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor
N Koshikawa et al.
CANCER RESEARCH (2005)
Tumor-specific gene expression using the survivin promoter is further increased by hypoxia
L Yang et al.
GENE THERAPY (2004)
Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression
S Ray et al.
HUMAN GENE THERAPY (2004)
Enhanced gene expression in breast cancer cells in vitro and tumors in vivo
HZ Lu et al.
MOLECULAR THERAPY (2002)
Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer
LQ Zhang et al.
MOLECULAR THERAPY (2002)
Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells
DE Post et al.
GENE THERAPY (2001)
Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors
L Wu et al.
GENE THERAPY (2001)
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
GL Semenza
JOURNAL OF APPLIED PHYSIOLOGY (2000)